New injection tested to shrink skin cancers before surgery
NCT ID NCT03889912
Summary
This study tested an experimental drug called cemiplimab, injected directly into skin cancer tumors before surgery. The main goal was to see if this approach was safe and how well patients tolerated it. Researchers also looked at whether the injections could shrink the tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alfred Health
Melbourne, Victoria, 3004, Australia
-
Dermatology Associates of the Palm Beaches
Delray Beach, Florida, 33445, United States
-
Duke Cancer Center
Durham, North Carolina, 27710, United States
-
Erasmus MC
Rotterdam, 3015 GD, Netherlands
-
Fremantle Dermatology
Fremantle, Western Australia, 6160, Australia
-
Inova Schar Cancer Institute
Fairfax, Virginia, 22031, United States
-
Maastricht University Medical Center
Maastricht, Limburg, 6202 AZ, Netherlands
-
Medical Dermatology Specialists
Phoenix, Arizona, 85006, United States
-
MetroDerm
Atlanta, Georgia, 30342, United States
-
Northeast Dermatology Associates
Beverly, Massachusetts, 01915, United States
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3000, Australia
-
Princess Alexandra Hospital
Brisbane, Queensland, 4102, Australia
-
Radboud University Medical Center
Nijmegen, Gelderland, 6500 HB, Netherlands
-
Rochester Dermatologic Surgery, P.C.
Victor, New York, 14564, United States
-
TCR Medical Corporation
San Diego, California, 92123, United States
-
The Netherlands Cancer Institute - Antoni van Leeuwenhoek
Amsterdam, North Holland, 1066 CX, Netherlands
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
University of Groningen, University Medical Centre Groningen
Groningen, 9700 RB, Netherlands
Conditions
Explore the condition pages connected to this study.